Mechanisms of the antinociceptive action of (-) Epicatechin obtained from the hydroalcoholic fraction of Combretum leprosum Mart & Eic in rodents

Journal of Biomedical Science

Volumn 19, Issue 1, 2012, Pages

  Lopes, Luciano Da Silva ^a   Marques, Rosemarie Brandin ^a   Fernandes, Heliana Barros ^a   Pereira, Sergio Da Silva ^a   Ayres, Mariane C C ^a   Chaves, Mariana Helena ^a   Almeida, Fernanda R C ^a  

^a FEDERAL UNIVERSITY OF PIAUÍ   (Brazil)

Author keywords

( ) epicatechin; Antinociception; Combretum leprosum; Glutamate; Serotonin and opioids

Indexed keywords

ADENOSINE TRIPHOSPHATE; ALCOHOL; ARGININE; ATROPINE; CAFFEINE; CENTRAL STIMULANT AGENT; COMBRETUM LEPROSUM EXTRACT; EPICATECHIN; GLIBENCLAMIDE; GLUTAMIC ACID; HYDROALCOHOL; MUSCARINIC RECEPTOR; MUSCLE RELAXANT AGENT; NALOXONE; ONDANSETRON; OPIATE RECEPTOR; PINDOLOL; PLANT EXTRACT; POTASSIUM CHANNEL; SEROTONIN 1 RECEPTOR; SEROTONIN 3 RECEPTOR; UNCLASSIFIED DRUG; YOHIMBINE; ADRENERGIC RECEPTOR; ANALGESIC AGENT; CATECHIN; CHOLINERGIC RECEPTOR; SEROTONIN RECEPTOR;

ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; COMBRETUM LEPROSUM; DRUG EFFECT; MALE; MOUSE; NONHUMAN; OPEN FIELD TEST; PLANT; PRIORITY JOURNAL; RECEPTOR BINDING; RODENT; ROTAROD TEST; SEROTONINERGIC SYSTEM; ANIMAL; CHEMICALLY INDUCED DISORDER; CHEMISTRY; COMBRETUM; DOSE RESPONSE; METABOLISM; NOCICEPTIVE PAIN;

ANIMALIA; COMBRETUM; MUS; RODENTIA;

ADENOSINE TRIPHOSPHATE; ANALGESICS; ANIMALS; CATECHIN; COMBRETUM; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUTAMIC ACID; MALE; MICE; NOCICEPTIVE PAIN; POTASSIUM CHANNELS; RECEPTORS, ADRENERGIC; RECEPTORS, CHOLINERGIC; RECEPTORS, OPIOID; RECEPTORS, SEROTONIN;

EID: 84869505993     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1186/1423-0127-19-68     Document Type: Article

References (26)

1. Uptake and metabolism of epicatechin and its access to the brain after oral ingestion. Abd El MM, Kuhnle G, Rechner AR, Schroeter H, Rose S, Jenner P, et al. Free Radic Biol Med 2002 33 1693 1702 10.1016/S0891-5849(02)01137-1 12488137 (Pubitemid 35462009)
2. Absorption, distribution, and secretion of epicatechin and quercetin in the rat. Abrahamse SL, Kloots WJ, Amelsvoort JMM, Nutri Res 2005 25 305 331 10.1016/j.nutres.2004.10.013 (Pubitemid 40354288)
3. Antioxidant evaluation of O-methylated metabolites of catechin, epicatechin and quercetin. Duẽas M, Gonzalez-Manzano S, Gonzale-Paramas A, Santos-Buelga C, J Pharm Biomed Anal 2009 51 443 449 19442472
4. Effects of () epigallocatechin-3-gallate on Na+currents in rat dorsal root ganglion neurons. Kim TH, Lim JM, Kim SS, Kim J, Park M, Song JH, Eur J Pharmacol 2009 604 20 26 10.1016/j.ejphar.2008.12.015 19111536
5. Effect of green tea catechins on plasma cholesterol level in cholesterol-fed rats. Muramatsu K, Fukuyo M, Hara Y, J Nutr Sci Vitaminol 1986 32 613 622 10.3177/jnsv.32.613 3585557
6. Protective Effect of Epicatechin Gallate and Quercetin on Lipid Peroxidation. Terao J, Piskula M, Yao Q, Arch Biochem Biophys 1994 308 278 284 10.1006/abbi.1994.1039 8311465 (Pubitemid 24172634)
7. Effects of EGCG on voltage-gated sodium channels in primary cultures of rat hippocampal CA1 neurons. Deng HM, Yin S-T, Yan D, Tang M-L, Li C-C, Chen J-T, et al. Toxicology 2008 252 1 8 10.1016/j.tox.2008.07.053 18706964
8. Polyphenol ()-epigallocatechin gallate targeting myocardial reperfusion limits infarct size and improves cardiac function. Kim CJ, Kim JM, Lee SR, Jang YH, Kim JH, Chun KJ, Korean J Anesthesiol 2010 58 169 175 10.4097/kjae.2010.58. 2.169 20498796
9. Inhibition of cardiac voltage-gated sodium channels by grape polyphenols. Wallace CHR, Baczká I, Jones L, Fercho M, Light PE, Br J Pharmacol 2006 149 657 265 10.1038/sj.bjp.0706897 17016511 (Pubitemid 44748058)
10. Nitric Oxide, Human diseases and the herbal products that affect the nitric oxide signalling pathway. Achike FI, Kwan C-Y, Clin Expl Pharmacol Physiol 2003 30 605 615 10.1046/j.1440-1681.2003.03885.x (Pubitemid 37229094)
11. In Vivo Comparison of the Bioavailability of (+)-Catechin, ()-Epicatechin and Their Mixture in Orally Administered Rats. Baba S, Osakabe N, Natsume M, Muto Y, Takizawa T, Terao J, Journal Nutr 2001 131 2885 2891 (Pubitemid 33063119)
12. Glutamate receptors and pain. Bleakman DA, Nisenbaun AE, Semin Cell Dev Biol 2006 17 592 604 10.1016/j.semcdb.2006.10.008 17110139 (Pubitemid 46389351)
13. Nitric oxide (NO) serves as a retrograde messenger to activate neuronal NO synthase in the spinal cord via NMDA receptors. Xu L, Mabuchi T, Katano T, Matsumura S, Okuda-Ashitaka E, Sakimura K, Mishina M, Ito S, Nitric Oxide 2007 17 18 24 17548218 (Pubitemid 47058293)
14. Nitric oxide and pain: Something old, something new. Miclescu A, Gordh T, Acta Anaesthesiol Scand 2009 53 1107 1120 10.1111/j.1399-6576.2009.02054.x 19702699
15. No NO, no pain? The role of nitric oxide and cGMP in spinal pain processing. Schmidtko A, Tegeder I, Geisslinger G, Trends Neurosci 2009 32 339 346 10.1016/j.tins.2009.01.010 19414201
16. Reduced response to the formalin test and lowered spinal NMDA glutamate receptor binding in adenosine A2A receptor knockout mice. Hussey MJ, Clark GD, Ledent C, Hourani SMO, Kitchen I, Pain 2007 129 287 294 10.1016/j.pain.2006.10. 014 17134834 (Pubitemid 46754569)
17. Induction of spinal cord neuronal nitric oxide synthase (NOS) after formalin injection in the rat hind paw. Lam HHD, Hanley DF, Trapp BD, Saito S, Raja S, Dawson TM, Yamaguchi H, Neurosci Lett 1996 210 201 204 10.1016/0304-3940(96)12702-6 8805130 (Pubitemid 26183332)
18. Possible role of NMDA receptors in antinociception induced by rilmenidine in mice in the formalin test. Sabetkasaie M, Khansefid N, Ladgevardi M, Eur J Pain 2007 11 535 541 10.1016/j.ejpain.2006.07.004 16934506 (Pubitemid 46670775)
19. Peripheral mechanisms of pain and analgesia. Stein C, Clark JD, Oh U, Vasko MR, Wilcox GL, Overland AC, Vanderah TW, Spencer RH, Brain Res Rev 2009 60 90 113 10.1016/j.brainresrev.2008.12.017 19150465
20. Serotonin receptor subtypes involved in the spinal antinociceptive effect of 5-HT in rats. Bardin L, Lavarenne J, Eschalier A, Pain 2000 86 11 18 10.1016/S0304-3959(99)00307-3 10779655 (Pubitemid 30211697)
21. Roles of serotonin receptors subtypes for the antinociception of 5-HT in the spinal cord of rats. Jeong CY, Choi J, Yoon MH, Eur J Pharmacol 2004 502 205 211 10.1016/j.ejphar.2004.08.048 15476746 (Pubitemid 39336486)
22. The role of adrenergic receptors and pain: The good, the bad, and the unknown. Carrol I, Mackey S, Gaeta R, S Anesth 2007 26 17 21
23. Interactions of descending serotonergic systems with other neurotransmitters in the modulation of nociception. Sawynok J, Reid A, Behav Brain Res 1995 73 63 68 10.1016/0166-4328(96)00072-1 (Pubitemid 26008763)
24. Inhibition of opioid release in the rat spinal cord by 2C adrenergic receptors. Chen W, Song B, Marvizon JC, Neuropharmacol 2008 54 944 953 10.1016/j.neuropharm.2008.02.002
25. Targeting the cholinergic system as a therapeutic strategy for the treatment of pain. Jones PG, Dunlop J, Neuropharmacol 2007 53 197 206 10.1016/j.neuropharm.2007.04.002 (Pubitemid 47187447)
26. Adenosine receptor mediates nicotine-induced antinociception in formalin test. Homayounfar H, Jamali-Raeufy N, Sahebgharani M, Zarrindast M-R, Pharmacol Res 2005 51 197 203 10.1016/j.phrs.2004.08.002 15661568 (Pubitemid 40127210)